OLAYINKA AYENI: Open Payments
NPI 1467645283 · SPRING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$550 in 21 payments from 8 companies in 2025. Trend: 2023 $137 · 2024 $355 · 2025 $550
Food & beverage: $550
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $139 |
| Otsuka America Pharmaceutical, Inc. | 5 | $111 |
| Supernus Pharmaceuticals, Inc. | 4 | $88 |
| ABBVIE INC. | 3 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| Tris Pharma Inc | 1 | $25 |
| Lundbeck LLC | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
Products named: COBENFY, REXULTI, Qelbree, VRAYLAR, CAPLYTA, Dyanavel XR, ABILIFY ASIMTUFII, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
